7:30 - 8:30 am |
Registration and Breakfast |
SESSION I: OBESITY AND LIFESTYLE MEDICINE |
|
8:35 - 8:40 am |
Chair Introduction and Opening Remarks |
8:40 - 9:00 am |
Benefits of Bariatric Surgery for the Cardiometabolic Patient |
9:00 - 9:20 am |
Obesity Pharmacotherapy: What’s on the Horizon? |
9:20 - 9:40 am |
Expert Panel Discussion and Q&A Moderator: Ken Fujioka, MD Panel: Robert E. Ratner, MD |
9:40 – 10:10 am |
Keynote The Special Diabetes Program for Indians: A Current and Future Legacy |
10:15 - 10:45 am |
Morning Break and Exhibits |
10:50 - 10:55 am |
Introduction: The Great Debate: Which Nutritional Plan is Best for Your Patient? |
10:55 - 11:40 am |
Part I: Weighing in on the Benefits of Nutritional Plans Alice H. Lichtenstein, D.Sc; Andrew M. Freeman, MD; Kim A. Williams, Sr., MD |
11:40 am - 12:00 pm |
Part II: Panel Discussion and Q&A Moderator: Ken Fujioka, MD Panel: Alice H. Lichtenstein, D.Sc; Andrew M. Freeman, MD; Kim A. Williams, Sr., MD |
12:00 pm |
Closing Remarks |
12:15 - 1:30 pm |
PME Lunch Symposium (NON–CME) Expert Insights: Managing Cardiovascular Risk Based on the Landmark CV Outcomes Trial (REDUCE-IT™) Krishnaswami Vijayaraghavan, MD Sponsored by Amarin Pharma, Inc. |
SESSION II: DYSLIPIDEMIA / ATHEROSCLEROSIS / THROMBOSIS |
|
1:45 pm |
Chair Introduction |
1:45 - 2:05 pm |
Updated Lipid Guidelines: What Do They Mean for Clinical Practice? |
2:05 - 2:25 pm |
Lp(a): When to Measure and How to Treat? |
2:25 - 2:45 pm |
Navigating the Treatment of Hypertriglyceridemia |
2:45 - 3:15 pm |
Challenging Patient Cases and Q&A Moderator: Christie M. Ballantyne, MD Panel: Alan Chait, MD; Pamela B. Morris, MD; Sotirios Tsimikas, MD; Salim S. Virani, MD |
3:20 - 3:50 pm |
Afternoon Break and Exhibits |
3:55 - 4:15 pm |
New Era of LDL-C Lowering: Evolving Therapies, Evolving Evidence, Evolving Guidance |
4:15 - 4:45 pm |
Antithrombotics in Diabetic Patients: Recent Clinical Trial Results Supported by an educational grant from AstraZeneca. |
4:45 - 5:05 pm |
Expert Panel Discussion and Q&A Moderator: Christie M. Ballantyne, MD |
5:05 - 5:10 pm |
Closing Remarks |
5:15 - 6:15 pm |
Reception on the Terrace |
6:30 - 7:00 am |
Registration |
7:10 - 8:25 am |
CME Breakfast Symposium Chair: JoAnn Lindenfeld, MD Presenters: Nancy K. Sweitzer, MD; Clyde W. Yancy, MD Multi-supported by educational grants from Abbott and Novartis Pharmaceuticals Corporation. |
SESSION III: HEART FAILURE AND HYPERTENSION |
|
8:35 am |
Chair Introduction |
8:35 - 9:10 am |
Hypertension: Where We Are and Where We Are Going? |
9:10 - 9:45 am |
End Stage HF: How to Treat and When to Refer? |
9:50 am - 10:20 am |
Morning Break and Exhibits |
10:20 - 11:00 am |
The Story Continues: Heart Failure and Type 2 Diabetes Supported by an educational grant from Boehringer Ingelheim and Lilly USA, LLC. |
11:00 - 11:35 am |
Heart Failure - Should Treatment Vary by Race or Gender? |
11:35 am - 12:05 pm |
Expert Panel Discussion and Q&A Moderator: George L. Bakris, MD |
12:15 - 1:30 pm |
CME Lunch Symposium Chair: Clyde W. Yancy, MD Presenters: Andy Y. Lee, MD; Peter A. McCullough, MD Supported by an educational grant from American Regent. |
SESSION IV: DIABETES MANAGEMENT |
|
1:40 - 1:45 pm |
Chair Introduction |
1:45 - 2:15 pm |
Setting a Target HbA1c: What Do the Guidelines Tell Us? |
2:15 - 2:45 pm |
Initial Combination Therapy versus Sequential Therapy |
2:45 - 3:15 pm |
Updates on Cardiovascular Outcomes Trials |
3:20 - 3:50 pm |
Afternoon Break and Exhibits |
3:55 - 4:25 pm |
Insulin: Benefits and Continued Challenges |
4:25 - 4:55 pm |
Impact of Real World Data on the Treatment of Patients with T2DM |
4:55 - 5:10 pm |
Expert Panel Discussion and Q&A Moderator: Jay S. Skyler, MD Panel: Lawrence Blonde, MD; Ralph A. DeFronzo, MD; Irl B. Hirsch, MD; Athena Philis-Tsimikas, MD |
5:10 - 5:15 pm |
Meeting Closing Remarks |
CMHC West Women’s Health Summit: Navigating Female Cardiometabolic Care |
|
7:00 - 8:00 am |
Registration and Breakfast |
8:00 - 8:05 am |
Introduction to CMHC Women's Health Summit |
8:05 - 8:30 am |
Cardiometabolic Risk in American Indians and Alaska Native Women |
8:30 - 8:55 am |
CVD Risk Assessment in Women |
8:55 - 9:20 am |
Aspirin Therapy for CVD Prevention in Women |
9:20 - 9:45 am |
The Intersection Between Breast Cancer and CVD Bonnie Ky, MD |
9:45 - 10:00 am |
Mini-break |
10:00 - 10:25 am |
Cardiometabolic Risk in PCOS and Implications for Management |
10:25 - 10:50 am |
Impact of Pregnancy on CV Risk Factors and ASCVD Risk |
10:50 - 11:15 am |
Postmenopausal Hormone Replacement Therapy and CVD: What is the risk? |
11:15 - 11:40 am |
Diabetes: The Relationship Disease — From a Woman’s Perspective |
11:40 - 11:45 am |
Conclusions to CMHC Women's Health Summit |
7:10 - 8:25 am |
CME Breakfast Symposium Chair: JoAnn Lindenfeld, MD Presenters: Nancy K. Sweitzer, MD; Clyde W. Yancy, MD Multi-supported by educational grants from Abbott and Novartis Pharmaceuticals Corporation. |
12:15 - 1:30 pm |
CME Lunch Symposium Chair: Clyde W. Yancy, MD Presenters: Andy Y. Lee, MD; Peter A. McCullough, MD Supported by an educational grant from American Regent. |
10:15 – 10:45 am |
Morning Break and Exhibits |
3:20 – 3:50 pm |
Afternoon Break and Exhibits |
9:50 – 10:20 am |
Morning Break and Exhibits |
3:20 – 3:50 pm |
Afternoon Break and Exhibits |
8:35 – 8:40 am |
Chair Introduction and Opening Remarks |
8:40 - 9:00 am |
Benefits of Bariatric Surgery for the Cardiometabolic Patient |
9:00 - 9:20 am |
Obesity Pharmacotherapy: What’s on the Horizon? |
9:20 - 9:40 am |
Expert Panel Discussion and Q&A< Moderator: Ken Fujioka, MD Panel: Robert E. Ratner, MD |
10:50 - 10:55 am |
Introduction: The Great Debate: Which Nutritional Plan is Best for Your Patient? |
10:55 - 11:40 am |
Part I: Weighing in on the Benefits of Nutritional Plans Alice H. Lichtenstein, D.Sc; Andrew M. Freeman, MD; Kim A. Williams, Sr., MD |
11:40 am - 12:00 pm |
Part II: Panel Discussion and Q&A Moderator: Ken Fujioka, MD Panel: Alice H. Lichtenstein, D.Sc; Andrew M. Freeman, MD; Kim A. Williams, Sr., MD |
12:00 pm |
Closing Remarks |
1:45 pm |
Chair Introduction |
1:45 - 2:05 pm |
Updated Lipid Guidelines: What Do They Mean for Clinical Practice? |
2:05 - 2:25 pm |
Lp(a): When to Measure and How to Treat? |
2:25 - 2:45 pm |
Navigating the Treatment of Hypertriglyceridemia |
2:45 - 3:15 pm |
Challenging Patient Cases and Q&A Moderator: Christie M. Ballantyne, MD Panel: Alan Chait, MD; Pamela B. Morris, MD; Sotirios Tsimikas, MD; Salim S. Virani, MD |
3:55 - 4:15 pm |
New Era of LDL-C Lowering: Evolving Therapies, Evolving Evidence, Evolving Guidance |
4:15 - 4:45 pm |
Antithrombotics in Diabetic Patients: Recent Clinical Trial Results Supported by an educational grant from AstraZeneca. |
4:45 - 5:05 pm |
Expert Panel Discussion and Q&A Moderator: Christie M. Ballantyne, MD |
5:05 - 5:10 pm |
Closing Remarks |
8:35 am |
Chair Introduction |
8:35 - 9:10 am |
Hypertension: Where We Are and Where We Are Going? |
9:10 - 9:45 am |
End Stage HF: How to Treat and When to Refer? |
10:20 - 11:00 am |
The Story Continues: Heart Failure and Type 2 Diabetes Supported by an educational grant from Boehringer Ingelheim and Lilly USA, LLC. |
11:00 - 11:35 am |
Heart Failure - Should Treatment Vary by Race or Gender? |
11:35 am - 12:05 pm |
Expert Panel Discussion and Q&A Moderator: George L. Bakris, MD |
1:40 - 1:45 pm |
Chair Introduction |
1:45 - 2:15 pm |
Setting a Target HbA1c: What Do the Guidelines Tell Us? |
2:15 – 2:45 pm |
Initial Combination Therapy versus Sequential Therapy |
2:45 - 3:15 pm |
Updates on Cardiovascular Outcomes Trials |
3:55 - 4:25 pm |
Insulin: Benefits and Continued Challenges |
4:25 - 4:55 pm |
Impact of Real World Data on the Treatment of Patients with T2DM |
4:55 - 5:10 pm |
Expert Panel Discussion and Q&A Moderator: Jay S. Skyler, MD Panel: Lawrence Blonde, MD; Ralph A. DeFronzo, MD; Irl B. Hirsch, MD; Athena Philis-Tsimikas, MD |
5:10 – 5:15 pm |
Meeting Closing Remarks |
9:40 – 10:10 am |
Keynote The Special Diabetes Program for Indians: A Current and Future Legacy |
12:15 - 1:30 pm |
PME Lunch Symposium (NON–CME) Expert Insights: Managing Cardiovascular Risk Based on the Landmark CV Outcomes Trial (REDUCE-IT™) Krishnaswami Vijayaraghavan, MD Sponsored by Amarin Pharma, Inc. |
5:15 – 6:15 pm |
Reception on the Terrace |
8:00 - 8:05 am |
Introduction to CMHC Women's Health Summit |
8:05 - 8:30 am |
Cardiometabolic Risk in American Indians and Alaska Native Women |
8:30 - 8:55 am |
CVD Risk Assessment in Women |
8:55 - 9:20 am |
Aspirin Therapy for CVD Prevention in Women |
9:20 - 9:45 am |
The Intersection Between Breast Cancer and CVD Bonnie Ky, MD |
10:00 - 10:25 am |
Cardiometabolic Risk in PCOS and Implications for Management |
10:25 - 10:50 am |
Impact of Pregnancy on CV Risk Factors and ASCVD Risk |
10:50 - 11:15 am |
Postmenopausal Hormone Replacement Therapy and CVD: What is the risk? |
11:15 - 11:40 am |
Diabetes: The Relationship Disease — From a Woman’s Perspective |
11:40 - 11:45 am |
Conclusions to CMHC Women's Health Summit |
SESSION II: DYSLIPIDEMIA / ATHEROSCLEROSIS / THROMBOSIS |
|
4:15 - 4:45 pm |
Antithrombotics in Diabetic Patients: Recent Clinical Trial Results Supported by an educational grant from AstraZeneca. |
SESSION IV: DIABETES MANAGEMENT |
|
2:45 - 3:15 pm |
Updates on Cardiovascular Outcomes Trials |
SESSION II: DYSLIPIDEMIA / ATHEROSCLEROSIS / THROMBOSIS |
|
4:15 - 4:45 pm |
Antithrombotics in Diabetic Patients: Recent Clinical Trial Results Supported by an educational grant from AstraZeneca. |
SESSION IV: DIABETES MANAGEMENT |
|
1:45 - 2:15 pm |
Setting a Target HbA1c: What Do the Guidelines Tell Us? |
2:15 - 2:45 pm |
Initial Combination Therapy versus Sequential Therapy |
2:45 - 3:15 pm |
Updates on Cardiovascular Outcomes Trials |
3:55 - 4:25 pm |
Insulin: Benefits and Continued Challenges |
4:25 - 4:55 pm |
Impact of Real World Data on the Treatment of Patients with T2DM |
4:55 - 5:10 pm |
Expert Panel Discussion and Q&A Moderator: Jay S. Skyler, MD Panel: Lawrence Blonde, MD; Ralph A. DeFronzo, MD; Irl B. Hirsch, MD; Athena Philis-Tsimikas, MD |
SESSION III: HEART FAILURE AND HYPERTENSION |
|
7:10 - 8:25 am |
CME Breakfast Symposium Chair: JoAnn Lindenfeld, MD Presenters: Nancy K. Sweitzer, MD; Clyde W. Yancy, MD Multi-supported by educational grants from Abbott and Novartis Pharmaceuticals Corporation. |
9:10 - 9:45 am |
End Stage HF: How to Treat and When to Refer? |
10:20 - 11:00 am |
The Story Continues: Heart Failure and Type 2 Diabetes Supported by an educational grant from Boehringer Ingelheim and Lilly USA, LLC. |
11:00 - 11:35 am |
Heart Failure - Should Treatment Vary by Race or Gender? |
11:35 am - 12:05 pm |
Expert Panel Discussion and Q&A Moderator: George L. Bakris, MD |
12:15 - 1:30 pm |
CME Lunch Symposium Chair: Clyde W. Yancy, MD Presenters: Andy Y. Lee, MD; Peter A. McCullough, MD Supported by an educational grant from American Regent. |
SESSION III: HEART FAILURE AND HYPERTENSION |
|
8:35 - 9:10 am |
Hypertension: Where We Are and Where We Are Going? |
11:35 am - 12:05 pm |
Expert Panel Discussion and Q&A Moderator: George L. Bakris, MD Panel: Clyde W. Yancy, MD |
SESSION II: DYSLIPIDEMIA / ATHEROSCLEROSIS / THROMBOSIS |
|
1:45 - 2:05 pm |
Updated Lipid Guidelines: What Do They Mean for Clinical Practice? |
2:05 - 2:25 pm |
Lp(a): When to Measure and How to Treat? |
2:25 - 2:45 pm |
Navigating the Treatment of Hypertriglyceridemia |
2:45 - 3:15 pm |
Challenging Patient Cases and Q&A Moderator: Christie M. Ballantyne, MD Panel: Alan Chait, MD; Pamela B. Morris, MD; Sotirios Tsimikas, MD; Salim S. Virani, MD |
3:55 - 4:15 pm |
New Era of LDL-C Lowering: Evolving Therapies, Evolving Evidence, Evolving Guidance |
4:45 - 5:05 pm |
Expert Panel Discussion and Q&A Moderator: Christie M. Ballantyne, MD |
SESSION I: OBESITY AND LIFESTYLE MEDICINE |
|
10:50 - 10:55 am |
Introduction: The Great Debate: Which Nutritional Plan is Best for Your Patient? |
10:55 - 11:40 am |
Part I: Weighing in on the Benefits of Nutritional Plans Alice H. Lichtenstein, D.Sc; Andrew M. Freeman, MD; Kim A. Williams, Sr., MD |
11:40 am - 12:00 pm |
Part II: Panel Discussion and Q&A Moderator: Ken Fujioka, MD Panel: Alice H. Lichtenstein, D.Sc; Andrew M. Freeman, MD; Kim A. Williams, Sr., MD |
SESSION I: OBESITY AND LIFESTYLE MEDICINE |
|
8:40 - 9:00 am |
Benefits of Bariatric Surgery for the Cardiometabolic Patient |
9:00 - 9:20 am |
Obesity Pharmacotherapy: What’s on the Horizon? |
9:20 - 9:40 am |
Expert Panel Discussion and Q&A Moderator: Ken Fujioka, MD Panel: Robert E. Ratner, MD |
WOMEN'S HEALTH SUMMIT |
|
8:00 - 8:05 am |
Introduction to CMHC Women's Health Summit |
8:05 - 8:30 am |
Cardiometabolic Risk in American Indians and Alaska Native Women |
8:30 - 8:55 am |
CVD Risk Assessment in Women |
8:55 - 9:20 am |
Aspirin Therapy for CVD Prevention in Women |
9:20 - 9:45 am |
The Intersection Between Breast Cancer and CVD Bonnie Ky, MD |
10:00 - 10:25 am |
Cardiometabolic Risk in PCOS and Implications for Management |
10:25 - 10:50 am |
Impact of Pregnancy on CV Risk Factors and ASCVD Risk |
10:50 - 11:15 am |
Postmenopausal Hormone Replacement Therapy and CVD: What is the risk? |
11:15 - 11:40 am |
Diabetes: The Relationship Disease — From a Woman’s Perspective |
11:40 - 11:45 am |
Conclusions to CMHC Women's Health Summit |